{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:23:40Z","timestamp":1791919420107,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-87551-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T02:48:12Z","timestamp":1741056492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Investigating the expression of anti\/pro-inflammatory cytokines in the pathogenesis and treatment of ulcerative colitis and its association with serum level of vitamin D"],"prefix":"10.1038","volume":"15","author":[{"given":"Amjad","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Yousefimashouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asadollah","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Nikkhoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Shokoohizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadali","family":"Khan Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Yousef","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Sheikhesmaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Khodaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"4","key":"87551_CR1","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.3390\/ijms24043817","volume":"24","author":"Y Haneishi","year":"2023","unstructured":"Haneishi, Y. et al. Inflammatory bowel diseases and gut microbiota. Int. J. Mol. Sci. 24(4), 3817  (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"87551_CR2","first-page":"2","volume":"5","author":"V Jairath","year":"2020","unstructured":"Jairath, V., Feagan, B. G. J. T. L. G. Feagan, and Hepatology, global burden of inflammatory bowel disease. Lancet Gastroenterol. 5(1), 2\u20133  (2020).","journal-title":"Lancet Gastroenterol."},{"key":"87551_CR3","doi-asserted-by":"crossref","unstructured":"Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology   142(1), 46\u201354. e42  (2012).","DOI":"10.1053\/j.gastro.2011.10.001"},{"issue":"10080","key":"87551_CR4","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro, R. et al. Ulcerative colitis. Lancet 389(10080), 1756\u20131770 (2017).","journal-title":"Lancet"},{"issue":"9573","key":"87551_CR5","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart, D. C. & Sandborn, W. J. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369(9573), 1641\u20131657 (2007).","journal-title":"Lancet"},{"issue":"2","key":"87551_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.tips.2016.10.014","volume":"38","author":"M Coskun","year":"2017","unstructured":"Coskun, M., Vermeire, S. & Nielsen, O. H. Novel targeted therapies for inflammatory bowel disease. Trends Pharmacol. Sci. 38(2), 127\u2013142 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"87551_CR7","unstructured":"Kasper, D. et al. Harrison\u2019s Principles of internal Medicine, 19e, Vol. 1 (Mcgraw-hill, 2015)."},{"issue":"1","key":"87551_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Primers 6(1), 74 (2020).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"87551_CR9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","volume":"89","author":"JD Feuerstein","year":"2014","unstructured":"Feuerstein, J. D. & Cheifetz, A. S. Ulcerative colitis: epidemiology, diagnosis, and management. Mayo Clin. Proc. 89(11), 1553\u20131563 (2014).","journal-title":"Mayo Clin. Proc."},{"issue":"12","key":"87551_CR10","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3748\/wjg.v20.i12.3255","volume":"20","author":"XR Xu","year":"2014","unstructured":"Xu, X. R. et al. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J. Gastroenterol. 20(12), 3255\u20133264 (2014).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"87551_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41577-024-01008-6","volume":"24","author":"MF Neurath","year":"2024","unstructured":"Neurath, M. F. Strategies for targeting cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 24(8), 559\u2013576 (2024).","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"87551_CR12","first-page":"e2004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu, C. et al. Cytokines: from clinical significance to quantification. Adv. Sci. (Weinh.)  8(15), e2004433 (2021).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"87551_CR13","doi-asserted-by":"crossref","unstructured":"Wautier, J. L. & Wautier, M. P. Pro- and anti-inflammatory prostaglandins and cytokines in humans: a mini review. Int. J. Mol. Sci. 24, 11 (2023).","DOI":"10.3390\/ijms24119647"},{"key":"87551_CR14","doi-asserted-by":"crossref","unstructured":"Umar, M., Sastry, K. S. & Chouchane, A. I. Role of vitamin D beyond the skeletal function: a review of the molecular and clinical studies. Int. J. Mol. Sci. 19, 6 (2018).","DOI":"10.3390\/ijms19061618"},{"issue":"5","key":"87551_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S2213-8587(23)00060-8","volume":"11","author":"JC Gallagher","year":"2023","unstructured":"Gallagher, J. C. & Rosen, C. J. Vitamin D: 100 years of discoveries, yet controversy continues. Lancet Diabetes Endocrinol. 11(5), 362\u2013374 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"87551_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick, M. F. Vitamin D deficiency. N Engl. J. Med. 357(3), 266\u2013281 (2007).","journal-title":"N Engl. J. Med."},{"key":"87551_CR17","doi-asserted-by":"crossref","unstructured":"Liu, C. et al. Cytokines: from clinical significance to quantification. Adv. Sci. 8(15), 2004433 (2021).","DOI":"10.1002\/advs.202004433"},{"key":"87551_CR18","doi-asserted-by":"crossref","unstructured":"Neurath, M. Strategies for targeting cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 2024, 1\u201318 (2024).","DOI":"10.1038\/s41577-024-01008-6"},{"key":"87551_CR19","doi-asserted-by":"crossref","unstructured":"Meyer, F. et al. Cytokines and intestinal epithelial permeability: a systematic review. Autoimmun. Rev. 2023, 103331  (2023).","DOI":"10.1016\/j.autrev.2023.103331"},{"key":"87551_CR20","doi-asserted-by":"publisher","first-page":"698693","DOI":"10.3389\/fimmu.2021.698693","volume":"12","author":"TT Pizarro","year":"2021","unstructured":"Pizarro, T. T., Dinarello, C. A. &  Cominelli, J.F.i.I. Cytokines and intestinal mucosal immunity. Front. Immunol. 12, 698693 (2021).","journal-title":"Front. Immunol."},{"key":"87551_CR21","doi-asserted-by":"crossref","unstructured":"Tavakoli, P. et al. A review of inflammatory bowel disease: a model of microbial, immune and neuropsychological integration. Public Health Rev. 42, 1603990  (2021).","DOI":"10.3389\/phrs.2021.1603990"},{"key":"87551_CR22","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai, Z., Wang, S. & Li, J. J. F. Treatment of inflammatory bowel disease: a comprehensive review. Front. Med. 8,  765474  (2021).","journal-title":"Front. Med."},{"key":"87551_CR23","doi-asserted-by":"crossref","unstructured":"Pithadia, A. B. & Jain, S. J. P. R. Treatment of inflammatory bowel disease (IBD). Pharmacol. Rep.  63(3), 629\u2013642  (2011).","DOI":"10.1016\/S1734-1140(11)70575-8"},{"key":"87551_CR24","doi-asserted-by":"crossref","unstructured":"Ogata, H. & Hibi, T. J. C. p. d.  Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr. Pharmaceut. Design 9(14), 1107\u20131113 (2003).","DOI":"10.2174\/1381612033455035"},{"issue":"3","key":"87551_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3748\/wjg.14.354","volume":"14","author":"PL Kozuch","year":"2008","unstructured":"Kozuch, P. L. &  Hanauer, S.B.J.W.j.o.g.W. Treatment of inflammatory bowel disease: a review of medical therapy. World J. Gastroenterol. 14(3), 354 (2008).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"87551_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12876-023-02985-z","volume":"23","author":"T Buran","year":"2023","unstructured":"Buran, T. et al. Molecular analyses of ADAMTS-1, -4, -5, and IL-17 a cytokine relationship in patients with ulcerative colitis. BMC Gastroenterol. 23(1), 345 (2023).","journal-title":"BMC Gastroenterol."},{"key":"87551_CR27","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Perlv\u00e1rez, M. L. et al. Role of serum cytokine profile in ulcerative colitis assessment. Inflamm. Bowel Dis. 18(10), 1864\u20131871  (2012).","DOI":"10.1002\/ibd.22865"},{"issue":"3","key":"87551_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0016-5085(94)90696-3","volume":"106","author":"JC Mansfield","year":"1994","unstructured":"Mansfield, J. C. et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106(3), 637\u2013642 (1994).","journal-title":"Gastroenterology"},{"issue":"9","key":"87551_CR29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/0929867323666161026124951","volume":"24","author":"J Abdo","year":"2017","unstructured":"Abdo, J., Rai, V. & Agrawal, D. K. Interplay of immunity and vitamin D: interactions and implications with current IBD therapy. Curr. Med. Chem. 24(9), 852\u2013867 (2017).","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"87551_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13104-024-06721-y","volume":"17","author":"MH Antwi","year":"2024","unstructured":"Antwi, M. H. et al. Investigation of serum level relationship of pro-inflammatory and anti-inflammatory cytokines with vitamin D among healthy Ghanaian population. BMC Res. Notes  17(1), 64 (2024).","journal-title":"BMC Res. Notes"},{"issue":"8","key":"87551_CR31","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.3390\/nu7085293","volume":"7","author":"D Barrera","year":"2015","unstructured":"Barrera, D. et al. Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies. Nutrients 7(8), 6465\u20136490 (2015).","journal-title":"Nutrients"},{"issue":"8","key":"87551_CR32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1080\/10408398.2017.1406333","volume":"59","author":"SM Barbalho","year":"2019","unstructured":"Barbalho, S. M., Goulart, R. A. & Gasparini, R. G. Associations between inflammatory bowel diseases and vitamin D. Crit. Rev. Food Sci. Nutr. 59(8), 1347\u20131356 (2019).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"8","key":"87551_CR33","doi-asserted-by":"publisher","first-page":"103136","DOI":"10.1016\/j.autrev.2022.103136","volume":"21","author":"C Triantos","year":"2022","unstructured":"Triantos, C. et al. Molecular basis of vitamin D action in inflammatory bowel disease. Autoimmun. Rev. 21(8), 103136 (2022).","journal-title":"Autoimmun. Rev."},{"key":"87551_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2017.12.023","volume":"103","author":"J Gubatan","year":"2018","unstructured":"Gubatan, J. et al. Higher serum vitamin D levels are associated with protective serum cytokine profiles in patients with ulcerative colitis. Cytokine 103, 38\u201345 (2018).","journal-title":"Cytokine"},{"key":"87551_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clnesp.2020.02.003","volume":"36","author":"S Karimi","year":"2020","unstructured":"Karimi, S. et al. Inflammatory biomarkers response to two dosages of vitamin D supplementation in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Clin. Nutr. ESPEN 36, 76\u201381 (2020).","journal-title":"Clin. Nutr. ESPEN"},{"issue":"17","key":"87551_CR36","first-page":"5635","volume":"22","author":"PL Sun","year":"2018","unstructured":"Sun, P. L. & Zhang, S. Correlations of 25-hydroxyvitamin D3 level in patients with ulcerative colitis with inflammation level, immunity and disease activity. Eur. Rev. Med. Pharmacol. Sci. 22(17), 5635\u20135639 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"87551_CR37","first-page":"408","volume":"119","author":"Z Vrablicova","year":"2018","unstructured":"Vrablicova, Z. et al. Influence of vitamin D on the expression of mRNA of cytokines in the mucosa of inflammatory bowel disease patients. Bratisl Lek Listy  119(7), 408\u2013415 (2018).","journal-title":"Bratisl Lek Listy"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87551-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87551-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87551-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T02:48:21Z","timestamp":1741056501000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-87551-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["87551"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-87551-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research was approved by the Ethics Committee of Hamadan University of Medical Sciences (IR.UMSHA.REC.1401.787). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"7569"}}